Dihydrodigoxin

CAS : 5297-10-9

Ref. 3D-FAA29710

Informations sur le produit

• Nom: Dihydrodigoxin
• Marque: Biosynth
• Description: Dihydrodigoxin is a cardiac glycoside that has been used in the treatment of congestive heart failure. It is usually administered orally and can be detected by fluorescence detector because it contains a fluorescent derivative. Dihydrodigoxin has been shown to decrease renal excretion of digoxin, which may lead to drug interactions. This drug also decreases the activity of several enzymes, including dehydroascorbic acid reductase (DHAR). DHAR catalyzes the conversion of dehydroascorbic acid to ascorbic acid, which is necessary for collagen synthesis. Dihydrodigoxin also causes preeclampsia in pregnant women and decreases blood flow to the uterus.

Propriétés chimiques

• Masse moléculaire: 783 g/mol
• Formule: C₄₁H₆₆O₁₄
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder